Finance

Beta
Lists
002940:SHE
Zhejiang Anglikang Pharmaceutical Co Ltd
CN¥31.75
-9.83%
(-3.46) 1D
Jun 5, 3:04:18 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002940...
Open
CN¥35.72
High
CN¥36.20
Low
CN¥31.69
Mkt. cap
6.40B
Avg. vol.
22.59M
Volume
28.67M
P/E ratio
50.38
52-wk high
CN¥68.80
52-wk low
CN¥16.15
EPS
CN¥0.63
Shares outstanding
201.73M
No. of employees
1K
Open
CN¥35.72
High
CN¥36.20
Low
CN¥31.69
Mkt. cap
6.40B
Avg. vol.
22.59M
Volume
28.67M
P/E ratio
50.38
52-wk high
CN¥68.80
52-wk low
CN¥16.15
EPS
CN¥0.63
Shares outstanding
201.73M
No. of employees
1K
News stories
From sources across the web
About Zhejiang Anglikang Pharmaceutical Co Ltd
CEO-
Employees1.24K
FoundedDec 30, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
378.83M
330.81M
369.64M
340.16M
Cost of goods sold
233.51M
202.07M
216.36M
215.60M
Cost of revenue
233.51M
202.07M
216.36M
215.60M
Research and development expenses
32.28M
37.79M
22.18M
34.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60.58M
63.63M
65.01M
61.98M
Operating expense
101.88M
104.52M
46.67M
94.14M
Total operating expenses
335.39M
306.59M
263.03M
309.73M
Operating income
43.44M
24.22M
106.61M
30.42M
Other non operating income
-921.76K
-1.04M
1.05M
-2.27M
EBT including unusual items
67.41M
17.80M
67.76M
24.18M
EBT excluding unusual items
44.37M
21.92M
106.59M
27.92M
Income tax expense
10.05M
396.68K
11.54M
792.30K
Effective tax rate
14.90%
2.23%
17.03%
3.28%
Other operating expenses
9.21M
3.62M
-44.31M
-95.92K
Net income
50.02M
11.76M
47.75M
17.65M
Net profit margin
13.20%
3.56%
12.92%
5.19%
Earnings per share
-
-
-
-
Interest and investment income
3.84M
3.40M
9.99M
2.78M
Interest expense
-3.36M
-3.28M
-11.07M
-3.00M
Net interest expenses
477.02K
120.15K
-1.07M
-224.39K
Depreciation and amortization charges
-
-
-
-
EBITDA
62.68M
45.95M
125.87M
-
Gain or loss from assets sale
53.31K
-53.31K
27.78K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more